Yemen gets $14.8million pledge to fight AIDS:
This article was originally published in Clinica
Executive Summary
The Yemen has been awarded $5.5m by the Geneva-based Global Fund to Fight AIDS, Tuberculosis and Malaria, to tackle HIV/AIDS over the next two years. A further $9.3m have been earmarked for disbursement over the following three years. Last year, the Global Fund granted the Yemen some $12m to support the national programme to fight malaria.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.